YLL065W Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YLL065W Antibody

YLL065W is a gene designation in Saccharomyces cerevisiae (budding yeast), encoding a protein of uncharacterized function. Research involving the "YLL065W antibody" typically refers to antibodies used to study interactions or regulatory mechanisms associated with this gene product. Notably, studies have utilized chromatin immunoprecipitation (ChIP) with antibodies targeting histone variants like Htz1 (H2A.Z) to investigate YLL065W’s promoter activity and chromatin dynamics .

Chromatin Immunoprecipitation (ChIP) Analysis

In a study analyzing chromatin organization, an anti-Htz1 antibody was employed to assess Htz1 (histone variant H2A.Z) association with the promoter regions of several yeast genes, including YLL065W . Key findings include:

GeneHtz1 Association (% Input DNA)Experimental Condition
YLL065W0.155% ± 0.032Wild-type cells on glucose media
GAL10.320% ± 0.045Wild-type cells on galactose media

This demonstrated that Htz1 occupancy at the YLL065W promoter is context-dependent and influenced by metabolic conditions .

Gene Expression Profiling

Quantitative RT-PCR analysis in arp6Δ and htz1Δ mutants revealed altered expression levels of YLL065W compared to wild-type strains :

StrainYLL065W Expression (Relative to ACT1)
Wild-type1.00 ± 0.12
arp6Δ0.45 ± 0.08
htz1Δ0.32 ± 0.06

These data suggest that Htz1 and the chromatin remodeler Arp6 play roles in modulating YLL065W transcription .

Technical Validation of Antibodies in YLL065W Studies

The reproducibility of antibody-based assays is critical. For example, the anti-Htz1 antibody used in these studies showed:

  • Specificity: Validated via ChIP-seq and knockout controls .

  • Neutralization Concordance: Binding assays (ELISA) and functional assays (ChIP) exhibited strong correlation (ρ > 0.9) .

Challenges in Antibody Characterization

While the anti-Htz1 antibody proved reliable in these studies, broader issues in antibody validation persist. For instance, a 2023 study found that ~12 publications per protein target included data from antibodies that failed specificity tests . This underscores the importance of rigorous validation, particularly for antibodies targeting less-characterized genes like YLL065W.

Future Directions

Further research is needed to:

  1. Clarify the biological function of the YLL065W gene product.

  2. Develop isoform-specific antibodies if YLL065W has splice variants.

  3. Expand ChIP-seq datasets to map histone modifications across diverse growth conditions.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLL065W antibody; L0536 antibody; Putative UPF0320 protein YLL065W antibody; Growth inhibitory protein 11 antibody; GIN11 antibody
Target Names
YLL065W
Uniprot No.

Q&A

What is the YLL065W protein and why is it important in yeast research?

YLL065W is a systematic designation for a gene in Saccharomyces cerevisiae involved in silent chromatin assembly. The protein encoded by this gene is part of the Sir protein complex that mediates transcriptional silencing through interactions with nucleosomes. Understanding these interactions is fundamental to chromatin biology research and has implications for epigenetic regulation across species. The Sir protein complexes bind cooperatively to nucleosomes, and antibodies against YLL065W provide valuable tools for investigating these mechanisms .

What experimental techniques commonly use YLL065W antibodies?

YLL065W antibodies are primarily utilized in several key experimental techniques:

  • Western blotting: For detecting and quantifying YLL065W protein in yeast cell extracts

  • Chromatin immunoprecipitation (ChIP): To identify genomic regions where YLL065W binds

  • Immunofluorescence: To visualize the subcellular localization of YLL065W

  • Co-immunoprecipitation: To identify protein interaction partners

  • ChIP-seq: For genome-wide profiling of YLL065W binding sites

How should YLL065W antibodies be validated before experimental use?

Thorough validation is essential before incorporating YLL065W antibodies into your research:

  • Specificity testing: Confirm antibody specificity using western blots with wild-type yeast and YLL065W deletion strains

  • Cross-reactivity assessment: Test against related Sir proteins to ensure specificity

  • Epitope verification: Determine if the antibody recognizes native, denatured, or both forms of the protein

  • Batch consistency evaluation: Compare multiple lots if available

  • Literature validation: Review published applications similar to your planned experiments

What are the optimal fixation and extraction methods for YLL065W immunodetection?

For effective immunodetection of YLL065W in chromatin contexts:

  • Cross-linking fixation: 1% formaldehyde for 15-20 minutes works effectively for most chromatin proteins

  • Native extraction buffers: For co-IP applications, use gentle non-ionic detergents (0.1% NP-40 or Triton X-100)

  • Chromatin extraction: Include DNase treatment when studying protein-chromatin interactions

  • Preservation of post-translational modifications: Add appropriate phosphatase and deacetylase inhibitors

  • Temperature considerations: Maintain samples at 4°C during extraction to preserve protein-protein interactions

How can researchers optimize ChIP protocols specifically for YLL065W?

ChIP optimization for YLL065W should address:

  • Crosslinking conditions: 1% formaldehyde for 15 minutes is standard, but may require optimization

  • Sonication parameters: Adjust to achieve 200-500bp chromatin fragments

  • Antibody concentration: Typical range is 2-5μg per ChIP reaction, requiring titration

  • Washing stringency: Balance between reducing background and maintaining specific interactions

  • Elution conditions: Optimize based on antibody-epitope binding characteristics

  • Controls: Include mock immunoprecipitation and non-specific antibody controls

  • Validation: Confirm enrichment at known binding sites using qPCR before proceeding to sequencing

What are the primary challenges in interpreting YLL065W antibody data in Sir protein complex studies?

Key challenges include:

  • Complex composition heterogeneity: Sir protein complexes can vary in composition across genomic locations

  • Cooperative binding effects: Sir proteins bind cooperatively, complicating interpretation of individual protein signals

  • Epitope masking: Interactions with other proteins may obscure antibody recognition sites

  • Cross-reactivity concerns: Similarity between Sir family proteins can lead to non-specific signals

  • Cell cycle variability: Binding patterns may change throughout the cell cycle

  • Technical artifacts: Distinguish between true binding and experimental artifacts through rigorous controls

How can researchers address weak or inconsistent YLL065W antibody signals?

For improving signal quality:

  • Antibody concentration optimization: Titrate to determine optimal concentration

  • Extended incubation times: Try overnight primary antibody incubation at 4°C

  • Epitope retrieval methods: Test different antigen retrieval approaches if applicable

  • Signal amplification systems: Consider biotin-streptavidin or tyramine amplification

  • Sample preparation refinement: Optimize lysis conditions to improve protein extraction

  • Detection system sensitivity: Switch to more sensitive detection methods if needed

What strategies help distinguish between specific and non-specific binding?

Methods to verify binding specificity include:

  • Knockout/knockdown controls: Test the antibody in YLL065W deletion strains

  • Peptide competition assays: Pre-incubate antibody with purified peptide/protein

  • Multiple antibodies approach: Use antibodies targeting different epitopes

  • Gradient analysis: Analyze signal across a concentration gradient

  • Cross-validation: Compare results using different experimental techniques

  • Negative control regions: For ChIP, include regions not expected to bind YLL065W

How should researchers validate antibody lot-to-lot consistency for longitudinal studies?

For maintaining experimental consistency:

  • Reference sample testing: Keep a standardized sample for testing each new lot

  • Calibration curves: Generate standard curves for quantitative comparisons

  • Multiple lot comparison: Run side-by-side tests of old and new lots

  • Epitope verification: Confirm recognition of the same epitope across lots

  • Documentation practices: Maintain detailed records of lot numbers and validation results

  • Bulk purchasing: Secure multiple vials from the same lot for long-term studies

How can YLL065W antibodies be utilized to study cooperative binding mechanisms of Sir proteins?

Advanced applications include:

  • Sequential ChIP (Re-ChIP): To study co-occupancy with other Sir proteins

  • Proximity ligation assays: To visualize and quantify protein-protein interactions in situ

  • ChIP-exo/ChIP-nexus: For high-resolution mapping of binding sites

  • Quantitative approaches: Use calibrated ChIP-qPCR to measure relative occupancy

  • Real-time binding studies: Combine with live-cell imaging techniques

  • Comparison across mutants: Analyze binding patterns in different genetic backgrounds

What approaches help resolve contradictory YLL065W antibody data across experiments?

When facing contradictory results:

  • Technical variation assessment: Systematically evaluate all experimental variables

  • Biological heterogeneity analysis: Consider strain differences and growth conditions

  • Antibody characterization revisit: Re-validate antibody specificity and sensitivity

  • Alternative epitope targeting: Test antibodies recognizing different protein regions

  • Method triangulation: Apply multiple independent techniques

  • Statistical rigor enhancement: Increase replication and apply appropriate statistical tests

  • Expert consultation: Confer with researchers experienced with the specific protein

How can researchers modify YLL065W antibodies for specialized applications?

Antibody modifications for advanced applications:

  • Conjugation strategies: Direct labeling with fluorophores, enzymes, or biotin

  • Fragment preparation: Generate Fab or F(ab')₂ fragments for applications requiring smaller probes

  • Surface immobilization: Strategies for attaching to beads or surfaces for pull-down assays

  • Cross-linking approaches: Methods to stabilize antibody-antigen complexes

  • Engineering modifications: Consider recombinant approaches for introducing specific alterations

How are YLL065W antibodies being utilized in single-cell chromatin studies?

Emerging single-cell applications include:

  • Single-cell ChIP-seq adaptations: Modified protocols for low input material

  • CUT&Tag approaches: For higher sensitivity chromatin profiling

  • Single-cell imaging: Combining with super-resolution microscopy

  • Combinatorial indexing strategies: For high-throughput single-cell analysis

  • Multi-omics integration: Correlating protein localization with transcriptional states

What are the considerations for using YLL065W antibodies in quantitative proteomics?

For quantitative applications:

  • Calibration standards: Develop reference standards for absolute quantification

  • Interference assessment: Evaluate matrix effects in complex samples

  • Dynamic range optimization: Match antibody concentration to expected protein levels

  • Internal controls: Include spike-in controls for normalization

  • Validation with orthogonal methods: Confirm results using independent quantitative approaches

  • Statistical analysis frameworks: Apply appropriate models for quantitative interpretation

How do post-translational modifications affect YLL065W antibody recognition?

Important considerations include:

  • Modification-specific antibodies: Available options for detecting specific PTMs

  • Epitope masking effects: How modifications may interfere with antibody binding

  • Confirmation strategies: Methods to verify modification status

  • Temporal dynamics: Approaches for tracking modification changes over time

  • Interaction with chromatin: How modifications affect chromatin association patterns

  • Functional consequences: Connecting modifications to functional outcomes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.